Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Blood Medicine Volume 6, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Expert Opinion

Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics

Albert Farrugia1 School of Surgery, QEII Medical Centre, The University of Western Australia (M509), Crawley, WA, Australia;2 College of Medicine, Medicine and Environment, Australian National University, Canberra, WA, AustraliaCorrespondence[email protected]

Declan Noone3 Irish Haemophilia Society, Dublin, Ireland

Uwe Schlenkrich4 Deutsche Hämophiliegesellschaft (DHG), Hamburg, Germany

Steffen Schlenkrich5 Am Holzbiel, Erfurt-Töttleben, Germany

Brian O’Mahony3 Irish Haemophilia Society, Dublin, Ireland

Josephine Cassar6 Faculty of Health, University of Canberra, Canberra, WA, Australia

Pages 185-195 | Published online: 15 Jun 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

E. Carlos Rodriguez-Merchan. (2020) The cost of hemophilia treatment: the importance of minimizing it without detriment to its quality. Expert Review of Hematology 13:3, pages 269-274.
Read now

Giancarlo Castaman & Silvia Linari. (2018) Prophylactic versus on-demand treatments for hemophilia: advantages and drawbacks. Expert Review of Hematology 11:7, pages 567-576.
Read now

Massimo Morfini & Ezio Zanon. (2016) Emerging drugs for the treatment of hemophilia A and B. Expert Opinion on Emerging Drugs 21:3, pages 301-313.
Read now

Articles from other publishers (1)

Miyuki Hsing‐Chun Hsieh, Shyh‐Shin Chiou, Tzu‐Chi Liao, Yea‐Huei Kao Yang & Edward Chia‐Cheng Lai. (2021) Trends in coagulation factor replacement therapy and medical costs in patients with haemophilia in Taiwan: A population‐based, 15‐year analysis. Haemophilia 27:2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references